DXB vs MEM

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

40LOW

MEM

MEMPHASYS FPO [MEM]

40LOW

Score Breakdown

DXB MEM
Technical
63
46
Catalyst
55
63
Sentiment
50
50
Fundamental
82
23
Momentum
44
61
Risk Gate
50
31

Key Metrics

DXB Metric MEM
$147.1MMarket Cap$21.6M
2.6MAvg Volume (20d)6.5M
N/AShort InterestN/A
$0.66552-Week High$0.009
$0.15852-Week Low$0.003
+8.7%Daily Change-12.5%
$0.250Reference Price$0.007
-594.5%ROE-87.4%
-219.9%Profit MarginN/A

Active Signals

DXB Signals

●Trading above both moving averages — the trend is your friend here
●Beating the Small Ords index — relative strength of 1.31, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (17% of range)
●Deeply negative margins (-220%)

MEM Signals

●MACD crossed bearish — momentum is fading
●Took a hit — down 12.5% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (0.6 quarters)
●4C filed 2026-07-15
●Very high P/S ratio (101.0x)
●Revenue in sharp decline (-96%)

Ask Scout AI to compare DXB and MEM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

DXB vs VHL →MEM vs VHL →EIQ vs EPN →DXB vs EPN →EPN vs MEM →
DXB Full Analysis → MEM Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).